Sarv Biolabs
Sarv Biolabs is a Private Indian company incorporated in 2005 and based in Himachal Pradesh, India. Sarv Biolabs operates in Pharmaceuticals & Chemicals (NIC 24234) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
Sarv Biolabs - Manufacturer of phytochemicals, active pharmaceutical ingredients, and standardized herbal extracts.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Sarv Biolabs.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 21 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +30d | filed |
| MGT-7 | FY2023-24 | 24 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 24 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Sarv Biolabs.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 362432835 | Axis Bank Ltd(Bank) | ₹9.17 Cr | 19 Sep 2022 | Satisfied |
| 387820257 | ICICI Bank Ltd(Bank) | ₹19.91 Cr | 27 Jan 2019 | Open |
| 390500197 | Kotak Mahindra Bank Ltd(Bank) | ₹6.27 Cr | 12 Mar 2023 | Satisfied |
| 338725151 | Kotak Mahindra Bank Ltd(Bank) | ₹8.02 Cr | 04 Jul 2019 | Open |
| 605375309 | State Bank of India(Bank) | ₹24.03 Cr | 27 Jan 2020 | Open |
Charge IDs, lenders & amounts for Sarv Biolabs.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹16.84 Cr | ₹8.15 L | ₹16.76 Cr | ₹25.29 Cr | 272 |
| FY2023-24 | ₹14.69 Cr | ₹10.93 L | ₹8.99 Cr | ₹15.34 Cr | 44 |
| FY2022-23 | ₹11.54 Cr | ₹1.56 L | ₹9.57 Cr | ₹18.72 Cr | 107 |
| FY2021-22 | ₹11.12 Cr | ₹30.75 L | ₹6.01 Cr | ₹13.37 Cr | 237 |
Audited financials & ratios for Sarv Biolabs.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹16.84 Cr | ₹14.69 Cr | ₹11.54 Cr | ₹11.12 Cr |
| Other income | ₹46.90 L | ₹20.93 L | ₹27.28 L | ₹30.51 L |
| Total income | ₹17.31 Cr | ₹14.90 Cr | ₹11.82 Cr | ₹11.42 Cr |
| Total expenses | ₹17.20 Cr | ₹14.76 Cr | ₹11.80 Cr | ₹11.03 Cr |
| Profit before tax | ₹10.60 L | ₹14.21 L | ₹2.03 L | ₹39.97 L |
| Profit / (Loss) after tax | ₹8.15 L | ₹10.93 L | ₹1.56 L | ₹30.75 L |
| Balance sheet | ||||
| Equity / Net worth | ₹16.76 Cr | ₹8.99 Cr | ₹9.57 Cr | ₹6.01 Cr |
| Borrowings | ₹2.31 Cr | ₹2.17 Cr | ₹3.67 Cr | ₹1.77 Cr |
| Current liabilities | ₹4.44 Cr | ₹2.92 Cr | ₹4.97 Cr | ₹3.60 Cr |
| Total liabilities | ₹8.52 Cr | ₹6.35 Cr | ₹9.15 Cr | ₹7.36 Cr |
| Current assets | ₹14.72 Cr | ₹6.75 Cr | ₹8.37 Cr | ₹6.00 Cr |
| Cash & equivalents | ₹3.42 Cr | ₹1.32 Cr | ₹1.06 Cr | ₹1.69 Cr |
| Total assets | ₹25.29 Cr | ₹15.34 Cr | ₹18.72 Cr | ₹13.37 Cr |
| Employees | 272 | 44 | 107 | 237 |
Audited financials & ratios for Sarv Biolabs.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹16.84 Cr | +18.8% | +24.8% | +5.6% |
| Profit after Tax | ₹8.15 L | +9.7% | +14.3% | -0.3% |
| Net Worth | ₹16.76 Cr | -1.3% | +18.5% | +16.7% |
| Employees | 272 | +16.7% | +3.6% | +1.1% |
Audited financials & ratios for Sarv Biolabs.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹16.84 Cr | ₹8.15 L | +0.48% | +36.28% | +0.49% | +0.32% | 0.14 | ₹6.19 L |
| FY2023-24 | ₹14.69 Cr | ₹10.93 L | +0.74% | -8.86% | +1.22% | +0.71% | 0.24 | ₹33.38 L |
| FY2022-23 | ₹11.54 Cr | ₹1.56 L | +0.14% | -13.08% | +0.16% | +0.08% | 0.38 | ₹10.79 L |
| FY2021-22 | ₹11.12 Cr | ₹30.75 L | +2.77% | -11.91% | +5.11% | +2.30% | 0.29 | ₹4.69 L |
Audited financials & ratios for Sarv Biolabs.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 2,73,85,010 | 67.06% |
| Institutional Investors | 1 | 52,46,139 | 12.85% |
| Public & Others | 51 | 82,04,052 | 20.09% |
Promoter, institutional & public holding for Sarv Biolabs.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
4 peersExternal data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.